Intellectual Product – Page 22 – Talk Bio

Actionable Insights Powered by AI

Bavarian Nordic Shares Surge on Strong Earnings and Major Mpox Vaccine Order Amid Global Health Emergency

9 months ago talkbio0Tagged Bavarian Nordic, earnings, Global Health Emergency, mpox vaccine, Report (document), Vaccines, World Health Organization

Bavarian Nordic, Mpox Vaccine, Global Health Emergency, WHO, Vaccine Order, Earnings Report

FDA Approves Updated COVID-19 Vaccines from Pfizer and Moderna for Enhanced Protection

9 months ago talkbio0Tagged Approved, authorization, COVID19 (disease), Emergency Situation, Guidelines, JN.1, KP.2, Lineage, Moderna, Pfizer, Pfizer/, RNA, Messenger, United States Food and Drug Administration, Vaccination, Vaccines, Variant

COVID-19 vaccines, FDA approval, mRNA vaccines, Pfizer, Moderna, updated vaccines, KP.2 variant, JN.1 lineage, emergency use authorization, vaccination guidelines.

Merck Acquires Curon’s Bispecific Antibody in $1.3B Deal; Legend Biotech Evaluates Options Amid Probes; Amgen’s FDA Filing Reveals Missing Adverse Events

9 months ago talkbio0Tagged Adverse event, amgen, Antibodies, Bispecific, CAR-T, Carvykti, China, Curon Biopharmaceutical, Evaluation procedure, File (record), Legend Biotech, Merck, United States Food and Drug Administration

Merck, Curon Biopharmaceutical , Bispecific antibody, Legend Biotech, Amgen, FDA filing, Adverse events, China investigations, CAR-T therapy, Carvykti

AstraZeneca Wins Patent Infringement Case Against Pfizer, Vacates $107.5M Jury Award

9 months ago talkbio0Tagged AstraZeneca, court, infringement, jury award, Legal patent, Pfizer

AstraZeneca, Pfizer, patent infringement, jury award, US court

Novo Nordisk’s Wegovy Approved in China: Implications and Future Challenges

9 months ago talkbio0Tagged Approved, China, competition, Expiration, function, Legal patent, Nordisk, Obesity, pharmaceutical market, semaglutide, Wegovy

Novo Nordisk, Wegovy, semaglutide, obesity treatment, China approval, generic competition, patent expiration, pharmaceutical market

Metagenomi Shifts Focus from ALS to Kidney Disease, Seeks New Partners

9 months ago talkbio0Tagged Amyotrophic Lateral Sclerosis, Base Editing, Gene Modification, Kidney Diseases, Metagenomi, Metagenomi drops, Programs - Publication Format, RIGS

Metagenomi, ALS, kidney disease, gene editing, base editing, RIGS, Metagenomi drops ALS program, new kidney disease partner

Evotec Announces 400 Job Cuts Amid Market Challenges

9 months ago talkbio0Tagged Challenge, Contract agreement, development aspects, Drug Discovery, Evotec, Manufacture, Market, restructuring

Evotec, job cuts, market challenges, restructuring, drug discovery, contract development, manufacturing

Metagenomi Halts ALS Research Following Biogen and Ionis Setbacks

9 months ago talkbio0Tagged Amyotrophic Lateral Sclerosis, Biogen, Drug Development, Drug Industry, Market, Metagenomi, Programs - Publication Format

Metagenomi, ALS program, Biogen, Ionis, pharmaceutical industry, drug development, layoffs, market challenges

Novo Nordisk Pursues FDA Filing for Once-Weekly Insulin and Semaglutide Combo After Icodec Rejection

9 months ago talkbio0Tagged Clinical Research, COMBINE-1, File (record), Icodec, IcoSema, Insulin, Nordisk, once-weekly, regulatory approval, semaglutide, United States Food and Drug Administration

Novo Nordisk, insulin icodec, semaglutide, FDA filing, type 2 diabetes, once-weekly insulin, IcoSema, COMBINE-1 study, regulatory approval

Lexicon Pharmaceuticals Reduces Workforce by 50% to Focus on Diabetes Drug

9 months ago talkbio0Tagged Diabetes, lexicon, restructuring, Zynquista

Lexicon Pharmaceuticals, workforce reduction, diabetes drug, restructuring, Zynquista